Christopher M Heaphy - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Christopher M Heaphy

Showing results (21-30 of 117) with videos related to

Pageof 12

Sort By:

Biorxiv : the Preprint Server for Biology|January 9, 2026

Functional inactivation of the telomerase chaperone TCAB1 primes cells for the activation of ALT in osteosarcomaJoshua Keegan, Sydney Sorbello, Joakin Mori, et al.

BMC Cancer|June 4, 2026

Complex structural variations functionally inactivate the telomerase chaperone TCAB1 in osteosarcomaJoshua Keegan, Sydney Sorbello, Joakin Mori, et al.

Breast Cancer Research and Treatment|September 12, 2008

Genomic instability demonstrates similarity between DCIS and invasive carcinomasChristopher M Heaphy, Marco Bisoffi, Nancy E Joste, et al.

Surgical Pathology Clinics|September 1, 2022

Prognostic and Predictive Biomarkers for Pancreatic Neuroendocrine TumorsWenzel M Hackeng, Hussein A Assi, Florine H M Westerbeke, et al.

The Journal of Urology|January 12, 2005

Association between cancer-free survival and telomere DNA content in prostate tumorsColleen A Fordyce, Christopher M Heaphy, Nancy E Joste, et al.

Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 24, 2020

Telomere length alterations and ATRX/DAXX loss in pituitary adenomasChristopher M Heaphy, Wenya Linda Bi, Shannon Coy, et al.

Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 8, 2009

The alternative lengthening of telomeres phenotype in breast carcinoma is associated with HER-2 overexpressionAndrea Proctor Subhawong, Christopher M Heaphy, Pedram Argani, et al.

Journal of Neuropathology and Experimental Neurology|June 22, 2019

ATRX Mutations in Pineal Parenchymal Tumors of Intermediate DifferentiationHaydee Martínez, Michelle Nagurney, Zi-Xuan Wang, et al.

Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 9, 2021

SMARCAL1 loss and alternative lengthening of telomeres (ALT) are enriched in giant cell glioblastomaJacqueline A Brosnan-Cashman, Christine M Davis, Bill H Diplas, et al.

International Journal of Cancer|February 2, 2006

Telomere DNA content and allelic imbalance demonstrate field cancerization in histologically normal tissue adjacent to breast tumorsChristopher M Heaphy, Marco Bisoffi, Colleen A Fordyce, et al.

Pageof 12

Search research articles

Showing results (21-30 of 117) with videos related to

Sort By:

Pageof 12

Biorxiv : the Preprint Server for Biology|January 9, 2026

Functional inactivation of the telomerase chaperone TCAB1 primes cells for the activation of ALT in osteosarcomaJoshua Keegan, Sydney Sorbello, Joakin Mori, et al.

BMC Cancer|June 4, 2026

Complex structural variations functionally inactivate the telomerase chaperone TCAB1 in osteosarcomaJoshua Keegan, Sydney Sorbello, Joakin Mori, et al.

Breast Cancer Research and Treatment|September 12, 2008

Genomic instability demonstrates similarity between DCIS and invasive carcinomasChristopher M Heaphy, Marco Bisoffi, Nancy E Joste, et al.

Surgical Pathology Clinics|September 1, 2022

Prognostic and Predictive Biomarkers for Pancreatic Neuroendocrine TumorsWenzel M Hackeng, Hussein A Assi, Florine H M Westerbeke, et al.

The Journal of Urology|January 12, 2005

Association between cancer-free survival and telomere DNA content in prostate tumorsColleen A Fordyce, Christopher M Heaphy, Nancy E Joste, et al.

Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 24, 2020

Telomere length alterations and ATRX/DAXX loss in pituitary adenomasChristopher M Heaphy, Wenya Linda Bi, Shannon Coy, et al.

Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 8, 2009

The alternative lengthening of telomeres phenotype in breast carcinoma is associated with HER-2 overexpressionAndrea Proctor Subhawong, Christopher M Heaphy, Pedram Argani, et al.

Journal of Neuropathology and Experimental Neurology|June 22, 2019

ATRX Mutations in Pineal Parenchymal Tumors of Intermediate DifferentiationHaydee Martínez, Michelle Nagurney, Zi-Xuan Wang, et al.

Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 9, 2021

SMARCAL1 loss and alternative lengthening of telomeres (ALT) are enriched in giant cell glioblastomaJacqueline A Brosnan-Cashman, Christine M Davis, Bill H Diplas, et al.

International Journal of Cancer|February 2, 2006

Telomere DNA content and allelic imbalance demonstrate field cancerization in histologically normal tissue adjacent to breast tumorsChristopher M Heaphy, Marco Bisoffi, Colleen A Fordyce, et al.

Pageof 12